Recent news on Lamivudine Zidovudine

Strides Arcolab ends JV with US firm  -  May 2, 2007
Business Standard,It has tentative approval for a fixed dose combination of anti-retroviral (ARV) drugs Lamivudine, Zidovudine 150 mg and 300 mg tablets, co-packaged with

Isolated Case of Counterfeit Combivir on the Market  -  Apr 12, 2007
Facts and Comparisons,GlaxoSmithKline is informing health care professionals of an incident of misbranding of Ziagen (abacavir sulfate) as Combivir (lamivudine/zidovudine).

The Top 14 Most Counterfeited Medications  -  Mar 28, 2007
ScienceBlogsTrizivir (abacavir/lamivudine/zidovudine - used in the treatment of HIV). 12. Viagra (sildenafil - you know this one for sure)

Strides gets FDA nod for AIDS drugs  -  Mar 25, 2007
Express Pharma,Strides Arcolab has received tentative approval from the USFDA for Lamivudine/Zidovudine 150 mg/300 mg tablets co-packaged with Nevirapine 200 mg tablets.

FDA Announces Tentative Approval Lamivudine/Zidovudine + Nevirapine  -  Mar 6, 2007
PharmaLive.com (press release),The lamivudine/zidovudine combination is a generic formulation of the FDA approved combination product, Combivir, manufactured by GlaxoSmithKline,

Avexa: trial success creates takeover speculation  -  Mar 22, 2007
Pharmaceutical Business ReviewFixed-dose combinations (FDCs) of NRTIs such as Gilead's Truvada (tenofovir/emtricitabine) and GSK's Combivir (lamivudine/zidovudine) are popular as they

Strides Arcolab receives NDA approval from USFDA  -  Mar 6, 2007
Moneycontrol.com (press release),Strides Arcolab Ltd. today announced that it has received tentative approval from the United States Food and Drug Administration for Lamivudine/Zidovudine

Strides Arcolab receives first NDA approval from USFDA  -  Mar 5, 2007
Equity Bulls,...front the United States Food and Drug Administration for Lamivudine / Zidovudine 150 mg / 300 mg Tablets co-packaged with Nevirapine 200 mg Tablets.

FDA Announces Tentative Approval of Triple Drug Fixed Dose Combination  -  Feb 6, 2007
PharmaLive.com (press release),The recommended regimen for the lamivudine-zidovudine-nevirapine tablet is one pill twice a day following an initial two week treatment with the individual

Indian pharmaceutical companies: innovative HIV drug reformulations  -  Feb 8, 2007
Pharmaceutical Business ReviewThe FDA has tentatively approved new HIV drug co-formulations combining lamivudine, zidovudine (both originally developed by GSK) and nevirapine (by

Clinical Cases in Neurology From Johns Hopkins -- Case 15: When a ...  -  Jan 31, 2007
Medscape (subscription)Medications at the time of presentation included trimethoprim-sulfamethoxazole, atazanavir, tenofovir, valacyclovir, and lamivudine/zidovudine.

Gilead Sciences Announces Fourth Quarter and Full Year 2006 ...  -  Feb 1, 2007
PharmaLive.com (press release),This study compares a once-daily regimen of Viread, Emtriva and Sustiva to a twice-daily regimen of Combivir(R) (lamivudine/zidovudine) with Sustiva once

FDA Safety Changes: Ortho Evra, Avastin, Trizivir  -  Dec 13, 2006
Medscape (subscription)...injection, and the risk for hepatic decompensation in patients receiving concomitant treatment with abacavir sulfate/lamivudine/zidovudine tablets and ...

96-Week Data From Gilead’s Study 934 Comparing Viread ® and ...  -  Dec 15, 2006
Business Wire (press release),...disoproxil fumarate), Emtriva ® (emtricitabine) and Sustiva ® (efavirenz) to a twice-daily regimen of Combivir ® (lamivudine/zidovudine) with Sustiva once ...

96-Week Data From Gilead's Study 934 Comparing Viread and Emtriva ...  -  Dec 15, 2006
PharmaLive.com (press release),...disoproxil fumarate), Emtriva(R) (emtricitabine) and Sustiva(R) (efavirenz) to a twice-daily regimen of Combivir(R) (lamivudine/zidovudine) with Sustiva once ...

New Data Reinforce Efficacy of Abacavir Sulfate/Lamivudine ...  Oct 12, 2006
SAN FRANCISCO, CA -- October 12, 2006 -- The HIV medication Trizivir(R) (abacavir sulfate, lamivudine, and zidovudine) administered twice daily provides ... -DG News Antiretroviral Treatment Strategies for Adults With HIV  Nov 2, 2006
ACTION Study: Efficacy and safety of abacavir/lamivudine/zidovudine [ABC/3TC/ZDV] BID versus lamivudine/zidovudine [3TC/ZDV] BID + atazanavir [ATV] QD in ART ... -Medscape (subscription) Gilead Sciences Announces Third Quarter 2006 Financial Results  Oct 18, 2006
...trial (Study 934) comparing a once-daily regimen of Viread, Emtriva and Sustiva to a twice-daily regimen of Combivir(R) (lamivudine/zidovudine) with Sustiva ... -Genetic Engineering News (press release), FDA Announces Tentative Approval of Fixed Does Lamivudine ...  Aug 24, 2006
24, 2006--The Food and Drug Administration (FDA), on August 23, 2006, granted tentative approval for a fixed dose tablet containing lamivudine/zidovudine 150 mg ... -PharmaLive.com

Van klinische proef van Gilead op 16de internationale AIDS ...  Aug 14, 2006
...disoproxil fumarate), Emtriva(R) (emtricitabine) and Sustiva(R) (efavirenz) to a twice-daily regimen of Combivir(R) (lamivudine/zidovudine) with Sustiva once ... -Netherlands Corporate News (persbericht)

The AIDS fight falters  Aug 20, 2006
...in a number of commercial forms – one example is the GlaxoSmithKline product Trizivir that combines the ingredients of lamivudine, zidovudine and abacavir in ... -The National

NEWS RELEASE  Aug 18, 2006
...tenofovir disoproxil fumarate), Emtriva® (emtricitabine) and Sustiva® (efavirenz) to a twice-daily regimen of Combivir® (lamivudine/zidovudine) with Sustiva ... -Financial News USA

FDA Announces Tentative Approval of Lamivudine/sidovudine Co ...  Jul 26, 2006
ROCKVILLE, Md., July 26, 2006--The Food and Drug Administration granted tentative approval on July 26, 2006 for lamivudine/zidovudine tablets co-packaged with ... -PharmaLive.com

Aurobindo receives US FDA approval for yet another 3-in-1 ARV ...  Aug 1, 2006
...several HIV patients. In many parts of the world, the regimen containing Lamivudine, Zidovudine and Abacavir is popular. Such therapy ... -Prdomain Business Register



International Approvals: Sifrol/Mirapexin and Truvada  Apr 24, 2006
The approval was based on data from a 48-week study that compared a once-daily regimen of tenofovir/emtricitabine with twice-daily lamivudine/zidovudine, 150 mg ... - Medscape (subscription)

Gilead Sciences Announces First Quarter 2006 Financial Results  Apr 18, 2006
Study 934) comparing a once-daily treatment regimen of Viread, Emtriva and Sustiva to a twice-daily regimen of Combivir(R) (lamivudine/zidovudine) with Sustiva ... - Genetic Engineering News



Aurobindo receives first NDA approval for HIV-1 drug from US FDA  Mar 16, 2006
The company's Lamivudine / zidovudine fixed dose combination tablet is a version of Combivir tablets manufactured by Glaxosmithkline, and the Efavirenz tablets ... - domain-B

Aurobindo gets 1st NDA approval for ARV product  Mar 16, 2006
The Company's Lamivudine / Zidovudine fixed dose combination tablet are a version of Combivir tablets manufactured by Glaxosmithkline, and the Efavirenz ... - India Infoline.com

Aurobindo gets new drug approval from USFDA  Mar 15, 2006
The company's Lamivudine/Zidovudine fixed dose combination tablet are a version of Combivir tablets manufactured by GlaxosmithKline, it said. - PTI. - Hindu Business Line

FDA approves HIV drug co-package  Apr 4, 2006
The regimen - consisting of lamivudine/zidovudine fixed-dose combination tablets and efavirenz tablets - is for the treatment of HIV-1 infection in adults. ... - myDNA.com

FDA Approves Drug Regimen To Treat AIDS  Apr 1, 2006
The regimen consists of lamivudine/zidovudine fixed dose combination tablets and efavirenz tablets. They are used to combat HIV-1 infection in adults. ... - All Headline News

Co-packaged AZT/3TC/efavirenz regimen approved for use in PEPFAR ...  Mar 9, 2006
US Food and Drug Administration this week granted tentative approval for a copackaged antiretroviral drug regimen, consisting of lamivudine/zidovudine (AZT/3TC ... - Aidsmap

FDA List Serve - Tentative approval of copackaged antiviral regim ...  Mar 9, 2006
Administration (FDA) on March 6, 2006, granted tentative approval for a copackaged antiretroviral drug regimen, consisting of lamivudine/zidovudine fixed dose ... - PharmaLive.com

Aurobindo to sell BMS' anti-AIDS drugs  Mar 17, 2006
Food and Drug Administration had given a tentative approval to its version of an anti-AIDS combination drug consisting of Lamivudine, Zidovudine and Efavirenz. - Reuters India

Aurobindo gets nod for FDC anti-AIDS drug  Mar 9, 2006
...tentative approval from the US Food and Drugs Administration for fixed dose combination (FDC) of anti-HIV/AIDS drugs lamivudine, zidovudine and efavirenz. ... - Economic Times

US FDA Grants Traditional Approval for Gilead's Once-Daily HIV ...  Mar 8, 2006
Study 934, a phase 3 open-label trial comparing a once-daily regimen of Viread, Emtriva and efavirenz to twice-daily Combivir® (lamivudine/zidovudine) and once ... - DG News

US FDA Grants Traditional Approval for Gilead's Once-Daily HIV ...  Mar 8, 2006
934, a Phase III open-label trial comparing a once-daily regimen of Viread, Emtriva and efavirenz to twice-daily Combivir(R) (lamivudine/zidovudine) and once ... - International News Service



Multi-component drug delivery system: An emerging trend  Feb 8, 2006
Inhibitors (NRTIs), which include abacavir (Ziagen), lamivudine, 3TC (Epivir), tenofovir (Viread), abacavir/lamivudine /zidovudine (Trizivir), lamivudine ... - Express Pharma Pulse,

Advances in First-Line and "Switch" Antiretroviral Strategies for ...  Feb 2, 2006
Cohen C, Elion R, DeJesus E, et al. 48 week analysis of efficacy and safety of once-daily (qd) abacavir/lamivudine/zidovudine (Trizivir) + tenofovir (TDF). ... - Medscape (subscription)

Multi-component drug delivery system: An emerging trend  Feb 8, 2006
Inhibitors (NRTIs), which include abacavir (Ziagen), lamivudine, 3TC (Epivir), tenofovir (Viread), abacavir/lamivudine /zidovudine (Trizivir), lamivudine ... - Express Pharma Pulse

Data Comparing Viread(R) and Emtriva(R) to Combivir(R) as Part of ...  Jan 18, 2006
...disoproxil fumarate), Emtriva(R) (emtricitabine) and Sustiva(R) (efavirenz) to a twice-daily regimen of Combivir(R) (lamivudine/zidovudine) with Sustiva once ... - Genetic Engineering News

Gilead HIV drug combo beats GSK rival in phase III trial  Jan 20, 2006
...of Viread (tenofovir disoproxil fumarate), Emtriva (emtricitabine) and Sustiva (efavirenz) to a regimen of Combivir (lamivudine/zidovudine) with Sustiva in ... - Pharmaceutical Business Review

NEWS RELEASE  Jan 19, 2006
...tenofovir disoproxil fumarate), Emtriva® (emtricitabine) and Sustiva® (efavirenz) to a twice-daily regimen of Combivir® (lamivudine/zidovudine) with Sustiva ... - Financial News USA

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional